These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27081457)

  • 41. Design and Synthesis of (
    Ko J; Lee J; Jung HJ; Ullah S; Jeong Y; Hong S; Kang MK; Park YJ; Hwang Y; Kang D; Park Y; Chun P; Yoo JW; Chung HY; Moon HR
    Antioxidants (Basel); 2022 Sep; 11(10):. PubMed ID: 36290640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-tyrosinase, antioxidant and antibacterial activities of gallic acid-benzylidenehydrazine hybrids and their application in preservation of fresh-cut apples and shrimps.
    Peng Z; Li Y; Tan L; Chen L; Shi Q; Zeng QH; Liu H; Wang JJ; Zhao Y
    Food Chem; 2022 Jun; 378():132127. PubMed ID: 35033723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic.
    Lachowicz JI; Nurchi VM; Crisponi G; Pelaez Mde G; Rescigno A; Stefanowicz P; Cal M; Szewczuk Z
    J Inorg Biochem; 2015 Oct; 151():36-43. PubMed ID: 26239546
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flavones as tyrosinase inhibitors: kinetic studies in vitro and in silico.
    Arroo RRJ; Sari S; Barut B; Özel A; Ruparelia KC; Şöhretoğlu D
    Phytochem Anal; 2020 May; 31(3):314-321. PubMed ID: 31997462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-tyrosinase, antioxidant, and antibacterial activities of novel 5-hydroxy-4-acetyl-2,3-dihydronaphtho[1,2-b]furans.
    Xia L; Idhayadhulla A; Lee YR; Wee YJ; Kim SH
    Eur J Med Chem; 2014 Oct; 86():605-12. PubMed ID: 25218909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and biological assessment of novel 4H-chromene-3-carbonitrile derivatives as tyrosinase inhibitors.
    Azimi M; Najafi Z; Bahmani A; Chehardoli G; Iraji A
    BMC Chem; 2024 Sep; 18(1):187. PubMed ID: 39342248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and biological evaluation of novel hydroxybenzaldehyde-based kojic acid analogues as inhibitors of mushroom tyrosinase.
    Xie W; Zhang H; He J; Zhang J; Yu Q; Luo C; Li S
    Bioorg Med Chem Lett; 2017 Feb; 27(3):530-532. PubMed ID: 28011217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies.
    Abbas Q; Ashraf Z; Hassan M; Nadeem H; Latif M; Afzal S; Seo SY
    Drug Des Devel Ther; 2017; 11():2029-2046. PubMed ID: 28740364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis and bioevaluation of novel umbelliferone analogues as potential mushroom tyrosinase inhibitors.
    Ashraf Z; Rafiq M; Seo SY; Babar MM; Zaidi NU
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):874-83. PubMed ID: 25643758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of Some Novel 2-Substitutedbenzyl-(4)7-phenyl-1H-benzo[d]imidazoles in Mild Conditions as Potent Anti-Tyrosinase and Antioxidant Agents.
    Doğan İS; Özel A; Birinci Z; Barut B; Sellitepe HE; Kahveci B
    Arch Pharm (Weinheim); 2016 Nov; 349(11):881-888. PubMed ID: 27681014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis and evaluation of cinnamic acid ester derivatives as mushroom tyrosinase inhibitors.
    Sheng Z; Ge S; Xu X; Zhang Y; Wu P; Zhang K; Xu X; Li C; Zhao D; Tang X
    Medchemcomm; 2018 May; 9(5):853-861. PubMed ID: 30108974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrated kinetic studies and computational analysis on naphthyl chalcones as mushroom tyrosinase inhibitors.
    Radhakrishnan S; Shimmon R; Conn C; Baker A
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4085-91. PubMed ID: 26318997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and biological evaluation of substituted aurone derivatives as potential tyrosinase inhibitors:
    Alshaye NA; Mughal EU; Elkaeed EB; Ashraf Z; Kehili S; Nazir Y; Naeem N; Abdul Majeed N; Sadiq A
    J Biomol Struct Dyn; 2023; 41(17):8307-8322. PubMed ID: 36255179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and Biological Activity Evaluation of 2-Cyanopyrrole Derivatives as Potential Tyrosinase Inhibitors.
    Hu YG; Gao ZP; Zheng YY; Hu CM; Lin J; Wu XZ; Zhang X; Zhou YS; Xiong Z; Zhu DY
    Front Chem; 2022; 10():914944. PubMed ID: 35783205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro and in vivo evidence of tyrosinase inhibitory activity of a synthesized (Z)-5-(3-hydroxy-4-methoxybenzylidene)-2-thioxothiazolidin-4-one (5-HMT).
    Bang E; Lee EK; Noh SG; Jung HJ; Moon KM; Park MH; Park YJ; Hyun MK; Lee AK; Kim SJ; Yang J; Park Y; Chun P; Moon HR; Chung HY
    Exp Dermatol; 2019 Jun; 28(6):734-737. PubMed ID: 30554432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of novel 1,2,4-triazole tethered β-hydroxy sulfides as bacterial tyrosinase inhibitors: synthesis and biophysical evaluation through
    Saeed S; Saif MJ; Zahoor AF; Tabassum H; Kamal S; Faisal S; Ashraf R; Khan SG; Nazeer U; Irfan A; Bhat MA
    RSC Adv; 2024 May; 14(22):15419-15430. PubMed ID: 38741974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, biological evaluation, molecular docking, MD simulation and DFT analysis of new 3-hydroxypyridine-4-one derivatives as anti-tyrosinase and antioxidant agents.
    Sadeghian S; Zare F; Khoshneviszadeh M; Hafshejani AF; Salahshour F; Khodabakhshloo A; Saghaie L; Goshtasbi G; Sarikhani Z; Poustforoosh A; Sabet R; Sadeghpour H
    Heliyon; 2024 Aug; 10(15):e35281. PubMed ID: 39170370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis, and biological evaluation of symmetrical azine derivatives as novel tyrosinase inhibitors.
    Karimian S; Kazemi F; Attarroshan M; Gholampour M; Hemmati S; Sakhteman A; Behzadipour Y; Kabiri M; Iraji A; Khoshneviszadeh M
    BMC Chem; 2021 Sep; 15(1):54. PubMed ID: 34587988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a Novel Class of Anti-Melanogenic Compounds, (
    Jeong Y; Hong S; Jung HJ; Ullah S; Hwang Y; Choi H; Ko J; Lee J; Chun P; Chung HY; Moon HR
    Antioxidants (Basel); 2022 May; 11(5):. PubMed ID: 35624809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.